Evidence map›Paper›PMID 29362380›Full record

ArticleScientific reports2018

Clinical Evaluation of the Immunochromatographic System Using Silver Amplification for the Rapid Detection of Mycoplasma pneumoniae.

Ho Namkoong, Masahiko Yamazaki, Masami Ishizaki, Ikumi Endo, Noriaki Harada, Megumi Aramaki, Yuko Tanaka, Sachiko Kaburagi, Masataka Ichikawa, Takanori Ohata and 5 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Comparison between DNA- and RNA-based nucleic acid amplification tests for detecting Mycoplasma pneumoniae in pediatric specimens.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Ho NamkoongDepartment of Pulmonary Medicine, Eiju General Hospital, Tokyo, Japan. hounamugun@gmail.com.
Masahiko YamazakiZama Children's Clinic, Kanagawa, Japan.
Masami IshizakiZama Children's Clinic, Kanagawa, Japan.
Ikumi EndoClinical Laboratory, Eiju General Hospital, Tokyo, Japan.
Noriaki HaradaClinical Laboratory, Eiju General Hospital, Tokyo, Japan.
Megumi AramakiDepartment of Pediatrics, Eiju General Hospital, Tokyo, Japan.
Yuko TanakaDepartment of Pediatrics, Eiju General Hospital, Tokyo, Japan.
Sachiko KaburagiDepartment of Pediatrics, Eiju General Hospital, Tokyo, Japan.
Masataka IchikawaIchikawa Children's Clinic, Kanagawa, Japan.
Takanori OhataDepartment of Pulmonary Medicine, Eiju General Hospital, Tokyo, Japan.
Shinji SakaguchiDepartment of Pulmonary Medicine, Eiju General Hospital, Tokyo, Japan.
Fumitake SaitoDepartment of Pulmonary Medicine, Eiju General Hospital, Tokyo, Japan.
Ayumi NakaoDepartment of Pediatrics, Eiju General Hospital, Tokyo, Japan.
Hideki YukiDepartment of Pulmonary Medicine, Eiju General Hospital, Tokyo, Japan.
Keiko MitamuraDepartment of Pediatrics, Eiju General Hospital, Tokyo, Japan.
Eiju General Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mycoplasma pneumoniae infection is conventionally diagnosed using serum antibody testing, microbial culture, and genetic testing. Recently, immunochromatography-based rapid mycoplasma antigen test kits have been developed and commercialised for rapid diagnosis of M. pneumoniae infection. However, as these kits do not provide sufficient sensitivity and specificity, a rapid test kit with improved accuracy is desired. The present prospective study evaluated a rapid M. pneumoniae diagnostic system utilizing a newly developed silver amplification immunochromatography (SAI) system. We performed dilution sensitivity test and the prospective clinical study evaluating the SAI system. The subjects of the clinical study included both children and adults. All patients suspected to have mycoplasma pneumonia (169 patients) were sequentially enrolled. Twelve patients did not agree to participate and 157 patients were enrolled in the study. The results demonstrate excellent performance of this system with 90.4% sensitivity and 100.0% specificity compared with real-time polymerase chain reaction. When compared with loop-mediated isothermal amplification (LAMP) methods, the results also demonstrate a high performance of this system with 93.0% sensitivity and 100.0% specificity. The SAI system uses a dedicated device for automatic analysis and reading, making it highly objective, and requires less human power, supporting its usefulness in clinical settings.

Indexed as

AdolescentAdultAgedAged, 80 and overAntigens, BacterialChromatography, AffinityFemaleHumansMaleMiddle AgedMycoplasma pneumoniaePneumonia, MycoplasmaProspective StudiesReagent Kits, DiagnosticSensitivity and SpecificitySilverAntigens, BacterialReagent Kits, DiagnosticSilver

Identifiers

PMID29362380
PMCPMC5780467
OpenAlexW2790987468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.